PLAUR and lung adenocarcinoma: In the same study, the authors demonstrated that chimeric antigen receptor (CAR) T cells that target uPAR efficiently eliminate senescent cells in vivo and extend the survival of mice with lung adenocarcinoma following treatment with MEK and CDK4/6 inhibitors, and ameliorated liver fibrosis in two independent models [193].